Evan Lockwood Rachlin
Director at Iambic Therapeutics IAM
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Oct 16, 2026 | Iambic Therapeutics IAM | Conversion 1,458,736 sh The same day as the company's 8-K filed Oct 16, 2026. | 1,458,736 | The same day as the company's 8-K filed Oct 16, 2026. | |
| Oct 16, 2026 | Iambic Therapeutics IAM | Conversion 410,762 sh The same day as the company's 8-K filed Oct 16, 2026. | 1,869,498 | The same day as the company's 8-K filed Oct 16, 2026. | |
| Oct 16, 2026 | Iambic Therapeutics IAM | Bought in the offering 718,750 sh at $16.00 At the offering price, the day after the 424B4. | $11.5M | 2,588,248 +38% | At the offering price, the day after the 424B4. |
| Oct 16, 2026 | Iambic Therapeutics IAM | Conversion 57,754 sh The same day as the company's 8-K filed Oct 16, 2026. | 57,754 | The same day as the company's 8-K filed Oct 16, 2026. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.